Legal, Legislative Quest To Expand Off-Label Part D Coverage Continues
The Medicare Rights Center is continuing a lawsuit seeking to expand coverage for off-label indications under the Medicare Part D prescription drug benefit after helping a beneficiary gain coverage of a drug to treat ovarian cancer
You may also be interested in...
New York federal court decides three-year-old case brought by the Medicare Rights Center against the federal government.
Medicare Part D drug plans should be able to consider a variety of evidence supporting off-label uses of drugs, not just the standard medical compendia list of accepted indications, a lawsuit challenging HHS' interpretation of congressional directives on this issue argues
Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.